dc.contributorUniversidade Estadual Paulista (Unesp)
dc.contributorUNIMEP
dc.date.accessioned2014-05-20T13:24:26Z
dc.date.accessioned2022-10-05T13:13:36Z
dc.date.available2014-05-20T13:24:26Z
dc.date.available2022-10-05T13:13:36Z
dc.date.created2014-05-20T13:24:26Z
dc.date.issued2006-09-01
dc.identifierJournal of Nanoscience and Nanotechnology. Stevenson Ranch: Amer Scientific Publishers, v. 6, n. 9-10, p. 3057-3061, 2006.
dc.identifier1533-4880
dc.identifierhttp://hdl.handle.net/11449/7569
dc.identifier10.1166/jnn.2006.487
dc.identifierWOS:000240865900051
dc.identifier5361569184579557
dc.identifier9129780536724256
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3884410
dc.description.abstractPraziquantel has been shown to be highly effective against all known species of Schistosoma infecting humans. Spherical nanoparticles made of poly(D,L-lactide-co-glycolide) acid with controlled size were designed as drug carriers. Praziquantel, a hydrophobic drug, was entrapped into the polymeric nanoparticles with 30% (w/w) of theoretical loading. The nanoparticles size was approximately of 350 nm with 66% of encapsulation efficiency. The everted gut sac model shows to be efficient to evaluate the drug permeation through the intestinal membrane. The results show that free praziquantel presents 4-fold times more permeation than praziquantel-loaded PLGA nanoparticles and physical mixture. For this drug, in special, this result can be interesting, since the nanoparticulate system can behave as a drug reservoir and/or to have a more localized effect in intestinal membrane for a prolonged period of time, since great amounts of parasites can be usually found in the mesenteric veins.
dc.languageeng
dc.publisherAmer Scientific Publishers
dc.relationJournal of Nanoscience and Nanotechnology
dc.relation1.354
dc.relation0,326
dc.rightsAcesso restrito
dc.sourceWeb of Science
dc.subjectnanoparticles
dc.subjectPLGA
dc.subjectpraziquantel
dc.subjectintestinal absorption
dc.titleDevelopment of praziquantel-loaded PLGA nanoparticles and evaluation of intestinal permeation by the everted gut Sac model
dc.typeArtigo


Este ítem pertenece a la siguiente institución